M&A Deal Summary |
|
---|---|
Date | 2023-09-25 |
Target | Vatica Health |
Sector | Information Technology |
Buyer(s) | Frazier Healthcare Partners |
Sellers(s) | Great Hill Partners |
Deal Type | Secondary Buyout |
Advisor(s) | Triple Tree (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Growth Capital Firm |
---|---|
Founded | 1991 |
PE ASSETS | 3.4B USD |
Size | Large |
Type | Sector Focused |
Frazier Healthcare Partners is a private equity and venture capital firm specializing in Growth buyout investment specifically targets businesses that deal Healthcare, Life Sciences, Pharmaceutical services, medical products, and related sectors. Frazier Healthcare Partners was formed in 1991 and is based in Seattle, Washington with an additional office in Palo Alto, California; Boston, Massachusetts; and Menlo Park, California.
DEAL STATS | # |
---|---|
Overall | 45 of 48 |
Sector: Information Technology M&A | 3 of 4 |
Type: Secondary Buyout M&A Deals | 7 of 10 |
State: Georgia M&A | 2 of 2 |
Country: United States M&A | 44 of 47 |
Year: 2023 M&A | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-03-30 |
United Digestive
Atlanta, Georgia, United States United Digestive is a provider of gastrointestinal physician services in the Southeast United States focused on providing high quality care to treat GI disorders, nutrition and digestive health. United Digestive was formed in 2018 and is based in Atlanta, Georgia. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-03-12 |
Alcresta Therapeutics
Newton, Massachusetts, United States Alcresta Therapeutics is a specialty pharmaceutical company focusing on discovering and developing a new generation of enzyme-based products that improve digestion and absorption of important nutrients. The company's lead program is a point-of-care, enzyme-based product that improves the bioavailability of long-chain fatty acids (such as DHA, EPA, and AA) for patients with impaired pancreatic output. Compromised pancreatic function is a complication of many diseases such as cystic fibrosis, chronic pancreatitis, and cancer as well as developmental immaturity, and Alcresta's products are aimed at meeting the nutritional needs of these patients. Alcresta Therapeutics was formed in 2011 and is based in Newton, Massachusetts. |
Sell | - |
Category | Private Equity Firm |
---|---|
Founded | 1998 |
PE ASSETS | 12.0B USD |
Size | Mega |
Type | Sector Agnostic |
Great Hill Partners is a private equity firm focused on growth equity and recapitalization investments in well established public and private companies valued put to $1 billion. Great Hill targets companies within consumer services, business services, financial technology, healthcare, internet, logistics, media, communications, technology services, software and transaction processing. The Firm invests in the range of $25 to $500 million per transaction. Great Hill prefers companies located in the US, but will also consider opportunities in Europe and Latin America. Great Hill Partners was formed in 1998 and is based in Boston, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 57 of 62 |
Sector: Information Technology M&A | 5 of 6 |
Type: Secondary Buyout M&A Deals | 11 of 11 |
State: Georgia M&A | 3 of 3 |
Country: United States M&A | 49 of 52 |
Year: 2023 M&A | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-09-06 |
Examity
Newton, Massachusetts, United States Examity is a provider of online proctoring and authentication solutions to higher education institutions, certification/ licensure bodies, corporations, and standardized testing organizations. Examity was founded in 2013 and is based in Newton, Massachusetts. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-01-18 |
eloomi
Copenhagen, Denmark eloomi is a cloud-based performance management and learning management system. eloomi was founded in 2015 and is based in Copenhagen, Denmark. |
Sell | - |